ZA98256B - Tachykinin antagonists - Google Patents
Tachykinin antagonistsInfo
- Publication number
- ZA98256B ZA98256B ZA98256A ZA98256A ZA98256B ZA 98256 B ZA98256 B ZA 98256B ZA 98256 A ZA98256 A ZA 98256A ZA 98256 A ZA98256 A ZA 98256A ZA 98256 B ZA98256 B ZA 98256B
- Authority
- ZA
- South Africa
- Prior art keywords
- tachykinin antagonists
- tachykinin
- antagonists
- Prior art date
Links
- 102000003141 Tachykinin Human genes 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 108060008037 tachykinin Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700597.9A GB9700597D0 (en) | 1997-01-14 | 1997-01-14 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA98256B true ZA98256B (en) | 1998-07-14 |
Family
ID=10805904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA98256A ZA98256B (en) | 1997-01-14 | 1998-01-13 | Tachykinin antagonists |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6107293A (es) |
| EP (1) | EP0964867B1 (es) |
| JP (2) | JP4306804B2 (es) |
| AR (1) | AR011521A1 (es) |
| AT (1) | ATE290546T1 (es) |
| AU (1) | AU5764298A (es) |
| CA (1) | CA2278057C (es) |
| CO (1) | CO4950614A1 (es) |
| DE (1) | DE69732715T2 (es) |
| ES (1) | ES2239368T3 (es) |
| GB (1) | GB9700597D0 (es) |
| PT (1) | PT964867E (es) |
| WO (1) | WO1998031704A2 (es) |
| ZA (1) | ZA98256B (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000005231A1 (en) * | 1998-07-20 | 2000-02-03 | Pfizer Limited | Fkbp inhibitors |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426331B1 (en) | 1998-07-08 | 2002-07-30 | Tularik Inc. | Inhibitors of STAT function |
| EP1158996A4 (en) | 1999-02-18 | 2005-01-12 | Kaken Pharma Co Ltd | NEW AMID DERIVATIVES AS GROWTH HORMONE SECRETION CONVEYORS |
| WO2001083517A1 (en) * | 2000-05-03 | 2001-11-08 | Tularik Inc. | Stat4 and stat6 binding dipeptide derivatives |
| US6884782B2 (en) | 2000-11-08 | 2005-04-26 | Amgen Inc. | STAT modulators |
| US20070219214A1 (en) * | 2006-02-01 | 2007-09-20 | Solvay Pharmaceuticals Gmbh | Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation |
| MY177591A (en) | 2006-10-16 | 2020-09-22 | Lion Corp | Nk1 receptor antagonist composition |
| ES2672099T3 (es) | 2011-07-04 | 2018-06-12 | Irbm - Science Park S.P.A. | Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal |
| EP4371613A3 (en) | 2018-02-26 | 2024-07-24 | Ospedale San Raffaele S.r.l. | Compounds for use in the treatment of ocular pain |
| WO2021180885A1 (en) | 2020-03-11 | 2021-09-16 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210669A (en) * | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
| GB8929070D0 (en) * | 1989-12-22 | 1990-02-28 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
| FR2719312B1 (fr) * | 1994-04-28 | 1996-06-14 | Adir | Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-01-14 GB GBGB9700597.9A patent/GB9700597D0/en active Pending
- 1997-12-29 AU AU57642/98A patent/AU5764298A/en not_active Abandoned
- 1997-12-29 US US09/341,626 patent/US6107293A/en not_active Expired - Lifetime
- 1997-12-29 ES ES97953927T patent/ES2239368T3/es not_active Expired - Lifetime
- 1997-12-29 PT PT97953927T patent/PT964867E/pt unknown
- 1997-12-29 JP JP53360998A patent/JP4306804B2/ja not_active Expired - Fee Related
- 1997-12-29 DE DE69732715T patent/DE69732715T2/de not_active Expired - Lifetime
- 1997-12-29 AT AT97953927T patent/ATE290546T1/de not_active IP Right Cessation
- 1997-12-29 WO PCT/EP1997/007307 patent/WO1998031704A2/en active IP Right Grant
- 1997-12-29 EP EP97953927A patent/EP0964867B1/en not_active Expired - Lifetime
- 1997-12-29 CA CA002278057A patent/CA2278057C/en not_active Expired - Fee Related
-
1998
- 1998-01-09 AR ARP980100097A patent/AR011521A1/es active IP Right Grant
- 1998-01-13 ZA ZA98256A patent/ZA98256B/xx unknown
- 1998-01-13 CO CO98001002A patent/CO4950614A1/es unknown
-
2005
- 2005-11-29 JP JP2005344056A patent/JP3817256B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000005231A1 (en) * | 1998-07-20 | 2000-02-03 | Pfizer Limited | Fkbp inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2278057A1 (en) | 1998-07-23 |
| PT964867E (pt) | 2005-07-29 |
| AR011521A1 (es) | 2000-08-30 |
| JP2006089499A (ja) | 2006-04-06 |
| EP0964867B1 (en) | 2005-03-09 |
| ES2239368T3 (es) | 2005-09-16 |
| JP2000516257A (ja) | 2000-12-05 |
| DE69732715T2 (de) | 2006-04-13 |
| GB9700597D0 (en) | 1997-03-05 |
| AU5764298A (en) | 1998-08-07 |
| ATE290546T1 (de) | 2005-03-15 |
| US6107293A (en) | 2000-08-22 |
| WO1998031704A3 (en) | 1998-09-11 |
| CO4950614A1 (es) | 2000-09-01 |
| DE69732715D1 (de) | 2005-04-14 |
| JP4306804B2 (ja) | 2009-08-05 |
| CA2278057C (en) | 2004-05-04 |
| JP3817256B2 (ja) | 2006-09-06 |
| EP0964867A2 (en) | 1999-12-22 |
| WO1998031704A2 (en) | 1998-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA983062B (en) | Gnrh antagonists | |
| AU1842995A (en) | N-acylpiperidine tachykinin antagonists | |
| HU9501249D0 (en) | Non-peptidyl tachykinin receptor antagonists | |
| AU4343796A (en) | Tachykinin antagonists | |
| EP0819005A4 (en) | 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS | |
| EP1007026A4 (en) | INTEGRIN ANTAGONISTS | |
| HU9602550D0 (en) | Gnrh antagonists | |
| EP0934305A4 (en) | INTEGRINE ANTAGONISTS | |
| EP0946164A4 (en) | INTEGRIN ANTAGONISTS | |
| HU9601176D0 (en) | Adhesion-receptor antagonists | |
| IL134993A0 (en) | New npy antagonists | |
| NZ324712A (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists | |
| HK1031726A1 (en) | Thrombin receptor antagonists | |
| IL134175A0 (en) | Endothelin antagonists | |
| IL142045A0 (en) | Naphthalenecarboxamides as tachykinin receptor antagonists | |
| IL134301A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
| HU9503191D0 (en) | Adhesion-receptor antagonists | |
| ZA98256B (en) | Tachykinin antagonists | |
| IL134155A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
| ZA985209B (en) | Endothelin antagonists | |
| ZA9510618B (en) | Tachykinin antagonists | |
| ZA987787B (en) | LFA-1 antagonists | |
| DK0964867T3 (da) | Tachykininantagonister | |
| GB9703015D0 (en) | Alpha v B3 antagonists | |
| GB9702922D0 (en) | Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists |